Skip to content

PMCF study to evaluate the safety and performance of the Natural Latex Female Contraceptive Condom.

A prospective, observational, multi-centric, non-randomized PMCF study to evaluate the safety and performance of the Natural Latex Female Contraceptive Condom. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091883
Enrollment
363
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Natural Latex Female Contraceptive Condom: Natural Latex Female Contraceptive Condom is a soft pliable rubber latex sheath, which lines the vagina. For Female Co

Sponsors

HLL Lifecare limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Mutually monogamous,current relationship greater than 3months -Already protected from pregnancy,e.g oral contraceptive,intrauterine device,subdermal implant,injectable,patch,male or female sterilization -Sexually active women -Sexually active,sufficient to meet protocol requirements agree to have penile-vaginal intercourse with frequency sufficient to meet protocol requirements -Agree to use only study female condoms during time of participation -Agree not to use male condom when using female condom in a single sex act -Agree not to use drugs or non-study devices that can affect sexual performance -Able to understand instructions for correct use of condoms -No known sexually transmitted infections including HIV/AIDS -Agree to use only lubricant(s) provided by the study -Agree not to wear any genital piercing jewellery while using study condoms -Willing and capable of following requirements of protocol,including willingness to respond to questions about reproductive and contraceptive history and use of condoms during interviews and on self-administered questionnaires.

Exclusion criteria

Exclusion criteria: -He/she is allergic or sensitive to the material(s) of the condoms. -Female partner is pregnant or desires to become so while participating in study. -Subject knowingly has a sexually transmitted infection. -Itinerant persons who cannot be able to complete the study, e.g., Migrant farm workers. -Male partner has known erectile or ejaculatory dysfunction. -Either partner is using any medications or preparation applied topically or intravaginally to the genitalia other than that supplied for the study. -Either partner is an employee of study sponsor or affiliated with clinical research center.

Design outcomes

Primary

MeasureTime frame
To confirm the performance of the Natural Latex Female Contraceptive Condom by assessing the total female condom failure, including both clinical and non-clinical failures. Additionally, the goal is to monitor the occurrence of each type of failure event. Clinical breakage, clinical slippage, clinical misdirection, clinical invagination are considered to assess the clinical failure events and non-clinical breakage is considered to assess the non-clinical failure events.Timepoint: required sample size is 363. Each couple will use four condoms over one month. The following month,they will come for a follow-up.

Secondary

MeasureTime frame
1.To observe any discomfort experienced by user/ partner -Burning -Vaginal/Penile Irritation -Itching -Rashes -Allergy 2.To monitor the presence of side effects/adverse events -Urinary tract infection -Mild bleeding or spotting due to improper insertion -Vaginal/Penile infection -Irritation in the genital area 3.Identifying & analyzing emerging risks 4.To observe clinical benefits & ensure continued acceptability of benefit- risk ratio 5.To identify contraindicated scenarios & possible systematic misuse or off-label use of the device 6.User acceptability - product experience & user satisfaction levels.Timepoint: required sample size is 363. Each couple will use four condoms over one month. The following month,they will come for a follow-up.

Countries

India

Contacts

Public ContactDr Roopa Kuchana

Dr. Roopas women health and fertility center

drroopasmfc@gmail.com917981970625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026